吉利德科學公司
US ˙ NasdaqGS ˙ US3755581036

SecurityGILD / Gilead Sciences, Inc.
InstitutionRYDEX VARIABLE TRUST - Biotechnology Fund Variable Annuity
Latest Disclosed Ownership3,628 shares
Latest Disclosed Value $ 402,236
RYDEX VARIABLE TRUST - Biotechnology Fund Variable Annuity reports 8.27% decrease in ownership of GILD / Gilead Sciences, Inc.

On August 27, 2025 - RYDEX VARIABLE TRUST - Biotechnology Fund Variable Annuity filed a NPORT-P form disclosing ownership of 3,628 shares of Gilead Sciences, Inc. (US:GILD) valued at $402,236 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 29, 2025 disclosing 3,955 shares of Gilead Sciences, Inc.. This represents a change in shares of -8.27% during the quarter. The current value of the position is $468,665 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-27 2025-06-30 NP Gilead Sciences EC US3755581036 3,628 -327 -8.27 402 -9.26 4.4703
2025-05-29 2025-03-31 NP Gilead Sciences EC US3755581036 3,955 -1,293 -24.64 443 -8.47 4.7078
2025-03-03 2024-12-31 NP Gilead Sciences EC US3755581036 5,248 -925 -14.98 485 -6.38 4.8597
2024-11-29 2024-09-30 NP Gilead Sciences EC US3755581036 6,173 -963 -13.49 518 5.73 4.6877
2024-08-29 2024-06-30 NP Gilead Sciences EC US3755581036 7,136 944 15.25 490 7.95 4.4635
2024-05-30 2024-03-31 NP Gilead Sciences EC US3755581036 6,192 -384 -5.84 454 -14.85 3.8465
2024-02-29 2023-12-31 NP Gilead Sciences EC US3755581036 6,576 -1,205 -15.49 533 -8.75 4.3662
2023-11-29 2023-09-30 NP Gilead Sciences EC US3755581036 7,781 -494 -5.97 583 -8.48 5.0487
2023-08-28 2023-06-30 NP Gilead Sciences EC US3755581036 8,275 3 0.04 638 -7.14 5.0328
2023-05-30 2023-03-31 NP Gilead Sciences EC US3755581036 8,272 -1,622 -16.39 686 -19.20 5.1985
2023-02-28 2022-12-31 NP Gilead Sciences EC US3755581036 9,894 -743 -6.99 849 29.42 5.1368
2022-11-29 2022-09-30 NP Gilead Sciences EC US3755581036 10,637 47 0.44 656 0.31 4.5793
2022-08-29 2022-06-30 NP Gilead Sciences EC US3755581036 10,590 -1,762 -14.26 655 -10.90 4.4906
2022-05-26 2022-03-31 NP Gilead Sciences EC US3755581036 12,352 -1,024 -7.66 734 -24.41 4.3392
2022-02-28 2021-12-31 NP Gilead Sciences EC US3755581036 13,376 1,197 9.83 971 14.24 4.2917
2021-11-29 2021-09-30 NP Gilead Sciences EC US3755581036 12,179 -780 -6.02 851 -4.71 3.5762
2021-08-27 2021-06-30 NP Gilead Sciences EC US3755581036 12,959 -769 -5.60 892 0.56 3.7374
2021-05-27 2021-03-31 NP Gilead Sciences EC US3755581036 13,728 -3,427 -19.98 887 -11.21 3.9924
2021-03-01 2020-12-31 NP Gilead Sciences EC US3755581036 17,155 -1,817 -9.58 999 -16.61 4.0703
2020-11-25 2020-09-30 NP Gilead Sciences EC US3755581036 18,972 1,139 6.39 1,199 -12.68 5.0036
2020-08-27 2020-06-30 NP Gilead Sciences EC US3755581036 17,833 -320 -1.76 1,372 1.11 5.5294
2020-06-01 2020-03-31 NP Gilead Sciences EC US3755581036 18,153 -1,157 -5.99 1,357 8.21 8.3067
2020-03-02 2019-12-31 NP Gilead Sciences EC US3755581036 19,310 1,138 6.26 1,255 8.95 5.8080
2019-11-27 2019-09-30 NP Gilead Sciences EC US3755581036 18,172 18,172 1,152 6.1101
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.